Update: Kestra Medical Technologies Slumps Pre-Bell After Fiscal Q1 Net Loss Widens Amid Surging Sales

MT Newswires Live

Yesterday

(Updates with the stock move in the headline and the first paragraph)

Kestra Medical Technologies' (KMTS) shares fell 9% in Tuesday's pre-market activity after the company reported a wider-than-anticipated fiscal Q1 loss, taking the shine off its revenue beat and improved full-year sales outlook.

The company reported a fiscal Q1 net loss late Monday of $0.75 per diluted share, widening from a loss of $0.50 a year earlier.

Analysts polled by FactSet expected a loss of $0.62.

Revenue for the quarter ended July 31 was $31.0 million, up from $19.3 million a year earlier.

Analysts expected $29 million.

For fiscal 2027, Kestra now expects revenue of $141 million, compared with its previous guidance of $137 million. Analysts expect $137 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/news/2667198643"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2667198643\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2667198643?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-15 17:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2667198643","market":"us","top_or_hot":-1,"title":"Update: Kestra Medical Technologies Slumps Pre-Bell After Fiscal Q1 Net Loss Widens Amid Surging Sales","media":"MT Newswires Live","content":"<html><body><p> (Updates with the stock move in the headline and the first paragraph)</p><p>Kestra Medical Technologies' (KMTS) shares fell 9% in Tuesday's pre-market activity after the company reported a wider-than-anticipated fiscal Q1 loss, taking the shine off its revenue beat and improved full-year sales outlook.</p><p>The company reported a fiscal Q1 net loss late Monday of $0.75 per diluted share, widening from a loss of $0.50 a year earlier.</p><p>Analysts polled by FactSet expected a loss of $0.62.</p><p>Revenue for the quarter ended July 31 was $31.0 million, up from $19.3 million a year earlier.</p><p>Analysts expected $29 million.</p><p>For fiscal 2027, Kestra now expects revenue of $141 million, compared with its previous guidance of $137 million. Analysts expect $137 million.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Update: Kestra Medical Technologies Slumps Pre-Bell After Fiscal Q1 Net Loss Widens Amid Surging Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpdate: Kestra Medical Technologies Slumps Pre-Bell After Fiscal Q1 Net Loss Widens Amid Surging Sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-15 17:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> (Updates with the stock move in the headline and the first paragraph)</p><p>Kestra Medical Technologies' (KMTS) shares fell 9% in Tuesday's pre-market activity after the company reported a wider-than-anticipated fiscal Q1 loss, taking the shine off its revenue beat and improved full-year sales outlook.</p><p>The company reported a fiscal Q1 net loss late Monday of $0.75 per diluted share, widening from a loss of $0.50 a year earlier.</p><p>Analysts polled by FactSet expected a loss of $0.62.</p><p>Revenue for the quarter ended July 31 was $31.0 million, up from $19.3 million a year earlier.</p><p>Analysts expected $29 million.</p><p>For fiscal 2027, Kestra now expects revenue of $141 million, compared with its previous guidance of $137 million. Analysts expect $137 million.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KMTS","symbol_name":"Kestra Medical Technologies Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2667198643","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2667198643","pubTimestamp":1789464710,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Kestra Medical Technologies'  shares fell 9% in Tuesday's pre-market activity after the company reported a wider-than-anticipated fiscal Q1 loss, taking the shine off its revenue beat and improved full-year sales outlook.The company reported a fiscal Q1 net loss late Monday of $0.75 per diluted share, widening from a loss of $0.50 a year earlier.Analysts polled by FactSet expected a loss of $0.62.Revenue for the quarter ended July 31 was $31.0 million, up from $19.3 million a year earlier.Analysts expected $29 million.For fiscal 2027, Kestra now expects revenue of $141 million, compared with its previous guidance of $137 million. Analysts expect $137 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"KMTS":"Kestra Medical Technologies Inc","BK4082":"医疗保健设备"},"translate_title":"更新：由于销售额飙升，第一财季净亏损扩大，Kestra Medical Technologies 的盘前下滑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KMTS":1},"content_text":"(Updates with the stock move in the headline and the first paragraph)Kestra Medical Technologies' (KMTS) shares fell 9% in Tuesday's pre-market activity after the company reported a wider-than-anticipated fiscal Q1 loss, taking the shine off its revenue beat and improved full-year sales outlook.The company reported a fiscal Q1 net loss late Monday of $0.75 per diluted share, widening from a loss of $0.50 a year earlier.Analysts polled by FactSet expected a loss of $0.62.Revenue for the quarter ended July 31 was $31.0 million, up from $19.3 million a year earlier.Analysts expected $29 million.For fiscal 2027, Kestra now expects revenue of $141 million, compared with its previous guidance of $137 million. Analysts expect $137 million.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}